| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |